Cargando…

Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials

BACKGROUND: High cost, poor compliance, and systemic toxicity have limited the use of pentavalent antimony compounds (SbV), the treatment of choice for cutaneous leishmaniasis (CL). Paromomycin (PR) has been developed as an alternative to SbV, but existing data are conflicting. METHODOLOGY/PRINCIPAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dae Hyun, Chung, Hye Jin, Bleys, Joachim, Ghohestani, Reza F.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637543/ https://www.ncbi.nlm.nih.gov/pubmed/19221595 http://dx.doi.org/10.1371/journal.pntd.0000381

Ejemplares similares

Topical paromomycin for New World cutaneous leishmaniasis
por: Sosa, Néstor, et al.
Publicado: (2019)

Effectiveness of Paromomycin on Cutaneous Leishmaniasis in Iran: A Systematic Review and Meta-Analysis
por: Moradzadeh, Rahmatollah, et al.
Publicado: (2019)

Topical Paromomycin and Gentamicin for New World Cutaneous Leishmaniasis in Panama
por: Monge-Maillo, Begoña, et al.
Publicado: (2014)

Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis
por: Wijnant, Gert-Jan, et al.
Publicado: (2017)

Nanoemulsions with Chloroaluminium Phthalocyanine and Paromomycin for Combined Photodynamic and Antibiotic Therapy for Cutaneous Leishmaniasis
por: Leal Pinto, Sandra Milena, et al.
Publicado: (2021)

Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama
por: Sosa, Néstor, et al.
Publicado: (2013)

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
por: Wiwanitkit, Viroj
Publicado: (2012)

Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
por: Pokharel, Pashupati, et al.
Publicado: (2021)

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2014)

Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
por: Musa, Ahmed M., et al.
Publicado: (2010)

Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
por: Sinha, Prabhat K., et al.
Publicado: (2011)

Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial
por: Hailu, Asrat, et al.
Publicado: (2010)

Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
por: Jamil, Kazi M., et al.
Publicado: (2015)

Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial
por: Musa, Ahmed M, et al.
Publicado: (2022)

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis
por: Verrest, Luka, et al.
Publicado: (2023)

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Parvez, Shabi, et al.
Publicado: (2020)

Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovani
por: Chawla, Bhavna, et al.
Publicado: (2011)

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
por: Musa, Ahmed, et al.
Publicado: (2012)

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
por: Rahman, Ridwanur, et al.
Publicado: (2017)

Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients
por: Verrest, Luka, et al.
Publicado: (2021)

Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment
por: Burgaña, Ander, et al.
Publicado: (2019)

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
por: Kimutai, Robert, et al.
Publicado: (2017)

Rodent control operations against zoonotic cutaneous leishmaniasis in rural Iran
por: Ershadi, Mohammad-Reza Yaghoobi, et al.
Publicado: (2005)

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia
por: Rojas Cabrera, Ernesto, et al.
Publicado: (2022)

Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
por: Okwor, Ifeoma, et al.
Publicado: (2012)

Effect of topical Nanoliposomes of Paromomycin on Rats Liver and Kidney
por: Kalantari, Heibatullah, et al.
Publicado: (2014)

Cryptosporidiosis in a renal transplant patient treated with paromomycin
por: Khalil-ur-Rahman,, et al.
Publicado: (2007)

In vitro Evaluation of Mannosylated Paromomycin-Loaded Solid Lipid Nanoparticles on Acute Toxoplasmosis
por: Khosravi, Mojdeh, et al.
Publicado: (2020)

In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains
por: Hu, Ya, et al.
Publicado: (2017)

Hypothesis: The potential application of doxorubicin against cutaneous leishmaniasis
por: Keighobadi, Masoud, et al.
Publicado: (2015)

Treatment of Cutaneous Leishmaniasis in Persian Medicine
por: MOZAFARI, Omid, et al.
Publicado: (2017)

Promoter Trapping in Microalgae Using the Antibiotic Paromomycin as Selective Agent
por: Vila, Marta, et al.
Publicado: (2012)

Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin
por: Shalev-Benami, Moran, et al.
Publicado: (2017)

Paromomycin sulfate is an effective treatment for balantidiasis in captive cynomolgus monkeys
por: Nakamura, Shinichiro, et al.
Publicado: (2019)

Prophylaxis using paromomycin of natural cryptosporidial infection in neonatal kids
por: Chartier, C., et al.
Publicado: (1996)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

Unusual Presentation of Cutaneous Leishmaniasis: Ocular Leishmaniasis
por: Doroodgar, Masoud, et al.
Publicado: (2017)

Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles
por: Sousa-Batista, Ariane J., et al.
Publicado: (2019)

Recurrent cutaneous leishmaniasis*
por: Gomes, Ciro Martins, et al.
Publicado: (2013)

Zosteriform cutaneous leishmaniasis
por: Tin, Sim Sai, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9mdhle5917jd99popg2j36l97i